Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Immune reconstitution inflammatory syndrome and natalizumab-Is it possible before removing the drug?
Steps Per Day Among Persons With Multiple Sclerosis: Variation by Demographic, Clinical, and Device Characteristics.
The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review.
Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Aggressive Multiple Sclerosis - whom, when and how.
Elevated Cerebrospinal Fluid Opening Pressure in a Pediatric Demyelinating Disease Cohort.
The right information can transform lives.
Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy.
Natalizumab therapy for multiple sclerosis.
Assessment of upper extremity function in multiple sclerosis: review and opinion.
Association between a Functional HLA-G 14-bp Insertion/deletion Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-analysis.
Topography of brain sodium accumulation in progressive multiple sclerosis.
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
Induced brain plasticity after a facilitation programme for autobiographical memory in multiple sclerosis: a preliminary study.
Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Neuromuscular adaptations to long-term progressive resistance training translates to improved functional capacity for people with multiple sclerosis and is maintained at follow-up.
FDA warns about the risks of unproven surgical therapy for multiple sclerosis.
Organic Causes of Erectile Dysfunction in Men Under 40.
Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.
Effect of vibration stimulation on dysbasia of spastic paraplegia in neuromyelitis optica: a possible example of neuronal plasticity.
Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis.
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
Sleep-disordered breathing in multiple sclerosis.
Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis.
Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells.
Pages
« first
‹ previous
…
377
378
379
380
381
382
383
384
385
…
next ›
last »